ABSTRACT:
In the present investigation an attempt was made to focus on the stability aspects of itraconazole hollow microsphere at refrigerated condition, room temperature and at accelerated condition. In stability studies, more emphasis given on the effect of different temperature conditions on appearance, % drug content, % buoyancy and % drug release of formulation over a period of 6 months. Apart from above studies, SEM and FTIR analysis was done to determine any change in morphology or chemical structure. The results showed non-significant changes in pharmaceutical properties. From result findings, it can be concluded that the itraconazole hollow microspheres are stable formulation to sustain the drug in upper GIT for prolonged period of time.
Cite this article:
Surbhi Rohilla, Dinesh Chandra Bhatt. Stability studies of Hollow Microspheres at Refrigerated, Normal and Accelerated Conditions. Research Journal of Pharmacy and Technology 2021; 14(10):5351-4. doi: 10.52711/0974-360X.2021.00933
Cite(Electronic):
Surbhi Rohilla, Dinesh Chandra Bhatt. Stability studies of Hollow Microspheres at Refrigerated, Normal and Accelerated Conditions. Research Journal of Pharmacy and Technology 2021; 14(10):5351-4. doi: 10.52711/0974-360X.2021.00933 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-10-51
REFERENCES:
1. ICH-International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use, Stability testing: photostability testing of new drug sub-stances and products, Q1B; 1996.
2. World Health Organization, Annex 2: Stability Testing of Active Pharmaceutical Ingredients and Finished Pharmaceutical Products, vol. 953 of WHO Technical Report Series; 2009.
3. Shah P, Rajshree M, Rane Y. Stability testing of pharmaceuticals-A global perspective. J. Pharm. Res. 2007; 6(1): 1-9.
4. Kushwaha P. Significance of Stability Studies on Degradation Product. Research J. Pharm. and Tech. 2009; 2(4): 621-627
5. Carstensen JT, Rhodes CT. Rational policies for stability testing. Clin. Res. Regul. Aff. 1993 Jan 1; 10(3): 177-85.
6. Rohilla S, Bhatt D C, Ahalwat S. Effect processing variables on the characteristics of itraconazole hollow microspheres. Int. J. App. Pharm. 2019; 11(6): 108-115.
7. Faizi SM, Rathi PN, Tajane SV, Burghate RM, \ Wasankar SR . Drug Delivery to Absorption Window through Floating Microspheres: A Review. Research J. Pharma. Dosage Forms and Tech. 2012; 4(3): 135-142 .
8. Firke S, Roge A, Ghiware N, Dhoot SB, Vadwalkar SM. Floating Microspheres as Gastro-Retentive Drug Delivery System: A Review. Research J. Pharm. and Tech. 2013; 6(12): 1452-1458.
9. Kawashima Y, Niwa T, Takeuchi H, Hino T, Ito Y. Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo). J. Control. Release. 1991; 16(3): 279-289.
10. Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur. J. Pharm. Biopharm. 2004; 57(2): 235-243.
11. Stability Testing Guidelines, Stability Testing of New Drug Substances and Products. ICH—Technical Coordination, EMEA, London; 2003.
12. Bajaj S, Singla D, Sakhuja N. Stability testing of pharmaceutical products. J. App. Pharm. Sci. 2012; 2(3): 129-138.
13. Rohilla S, Bhatt DC, Ahalwat S. Fabrication of potential gastroretentive microspheres of itraconazole for stomach-specific delivery: Statistical optimization and in vitro evaluation. J. App. Pharm. Sci. 2020; 10(03):119-27.
14. Najmuddin M, Ahmed A, Shelar S, Patel V, Khan T. Floating microspheres of ketoprofen: formulation and evaluation. Int. J. Pharm. Pharm. Sci. 2010; 2(2): 83-87.
15. Gawade P, Agrawal S. Design and characterization of eudragit coated Chitosan microspheres of deflazacort for colon targeting. J. Pharm. Res. 2012; 5(9): 4867-70.
16. Jain SK, Agrawal GP, Jain NK. Floating microspheres as drug delivery system: newer approaches. Curr. Drug Deliv. 2008; 5(3): 220-223.